Skip to main content
Top
Published in: Archives of Osteoporosis 1/2020

01-12-2020 | Osteoporosis | Original Article

The urinary β2 microglobulin-creatinine ratio is inversely associated with lumbar spine bone mineral density in the elderly Chinese males

Authors: Xun Zhou, Wei Hong, Weijun Chen, Xinhui Feng, Zhenxing Zhang, Xiaoli Zhang, Chensheng Fu, Jing Xiao, Zhibin Ye

Published in: Archives of Osteoporosis | Issue 1/2020

Login to get access

Abstract

Summary

Renal tubule cells play a pivotal role in maintaining bone homeostasis. Hence, renal tubular function may be associated with bone mineral density. Our study found that urinary β2 microglobulin-creatinine ratio (UBCR) levels correlated negatively with lumbar spine bone mineral density (BMD) and T and Z values, and may be a marker for osteoporosis in Chinese elderly male adults.

Purpose

To study the association of UBCR levels with BMD and the predictive value of UBCR for osteoporosis in elderly Chinese male adults.

Methods

A cross-sectional study of 149 (65 to 85 years, 69.7 ± 4.6) Chinese male adults who underwent health checkups in Huadong Hospital in Shanghai China was conducted. BMD was measured by dual-energy X-ray absorptiometry. The clinical variables and BMD of the participants in the low UBCR group (B1, UBCR < 300 μg/g) and the high UBCR group (B2, UBCR ≥ 300 μg/g) were compared. Associations between UBCR with clinical variables and BMD were analyzed by Pearson’s correlation coefficient and multiple regression analysis. BMD and T and Z values were compared between the B1 and B2 groups. The odds ratios (ORs) for dose-dependent increases in osteoporosis between B1 and B2 were analyzed by binary logistic regression analysis. The area under the receiver operating characteristic (ROC) curve was used to analyze the capacity of UBCR to predict osteoporosis.

Results

UBCR was significantly higher in the osteoporosis group. After adjusting for multiple confounders, UBCR levels correlated negatively with BMD and T and Z values of the lumbar spine. Lumbar spine BMD and T and Z values were significantly lower in the B2 UBCR group than in the B1 UBCR group. Compared with the B1 participants, the ORs for “osteoporosis” were 12.401 times higher in B2 participants (P = 0.005) by binary logistic regression analysis after adjusting for potential confounders. The UBCR index (cutoff = 362.48 μg/g) had a sensitivity of 78.6% and a specificity of 68.7% for identifying osteoporosis, with an area under the ROC curve of 0.760.

Conclusions

These results suggest that UBCR levels correlate negatively with lumbar spine BMD and T and Z values and may serve as a marker for osteoporosis in Chinese elderly male adults.
Literature
1.
go back to reference Khosla S (2020) Update in male osteoporosis. J Clin Endocrinol Metab 95:3–10 Khosla S (2020) Update in male osteoporosis. J Clin Endocrinol Metab 95:3–10
3.
go back to reference Bernier GM, Conrad ME (1969) Catabolsm of human beta-2-microglobulin by the rat kidney. Am J Phys 217(5):1359–1362 Bernier GM, Conrad ME (1969) Catabolsm of human beta-2-microglobulin by the rat kidney. Am J Phys 217(5):1359–1362
4.
go back to reference Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R (2007) Urinary biomarkers in septic acute kidney injury. Intensive Care Med 33(7):1285–1296PubMed Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R (2007) Urinary biomarkers in septic acute kidney injury. Intensive Care Med 33(7):1285–1296PubMed
5.
go back to reference Songprasert N, Sukaew T, Kusreesakul K, Swaddiwudhipong W, Padungtod C, Bundhamcharoen K (2015) Additional burden of diseases associated with cadmium exposure: a case study of cadmium contaminated rice fields in Mae Sot District, Tak Province, Thailand. Int J Environ Res Public Health 12(8):9199–9217PubMedPubMedCentral Songprasert N, Sukaew T, Kusreesakul K, Swaddiwudhipong W, Padungtod C, Bundhamcharoen K (2015) Additional burden of diseases associated with cadmium exposure: a case study of cadmium contaminated rice fields in Mae Sot District, Tak Province, Thailand. Int J Environ Res Public Health 12(8):9199–9217PubMedPubMedCentral
6.
go back to reference Satarug S (2018) Dietary Cadmium Intake and Its Effects on Kidneys[J]. Toxics:6(1) Satarug S (2018) Dietary Cadmium Intake and Its Effects on Kidneys[J]. Toxics:6(1)
7.
go back to reference WHO F (2010) Food and agriculture organization and World Health Organization, in the seventy-third meeting. Geneva, Switzerland WHO F (2010) Food and agriculture organization and World Health Organization, in the seventy-third meeting. Geneva, Switzerland
8.
go back to reference van den Brand JA, Hofstra JM, Wetzels JF (2011) Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6(12):2846–2853PubMedPubMedCentral van den Brand JA, Hofstra JM, Wetzels JF (2011) Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6(12):2846–2853PubMedPubMedCentral
9.
go back to reference Joyce E, Glasner P, Ranganathan S, Swiatecka-Urban A (2017) Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatr Nephrol 32(4):577–587PubMed Joyce E, Glasner P, Ranganathan S, Swiatecka-Urban A (2017) Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatr Nephrol 32(4):577–587PubMed
10.
go back to reference Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG (2014) Urinary excretion of beta2-microglobulin as a prognostic marker in immunoglobulin A nephropathy. Korean J Intern Med 29(3):334–340PubMedPubMedCentral Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG (2014) Urinary excretion of beta2-microglobulin as a prognostic marker in immunoglobulin A nephropathy. Korean J Intern Med 29(3):334–340PubMedPubMedCentral
11.
go back to reference Ikeda A et al (2009) In a non-diabetic Japanese population, the combination of macroalbuminuria and increased urine beta 2-microglobulin predicts a decline of renal function: the Takahata study. Nephrol Dial Transplant 24(3):841–847PubMed Ikeda A et al (2009) In a non-diabetic Japanese population, the combination of macroalbuminuria and increased urine beta 2-microglobulin predicts a decline of renal function: the Takahata study. Nephrol Dial Transplant 24(3):841–847PubMed
12.
go back to reference Nishijo M et al (2006) Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment. Occup Environ Med 63(8):545–550PubMedPubMedCentral Nishijo M et al (2006) Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment. Occup Environ Med 63(8):545–550PubMedPubMedCentral
13.
go back to reference Nishijo M, Nakagawa H, Morikawa Y, Kuriwaki JI, Miura K, Kido T, Nogawa K (2004) Mortality in a cadmium polluted area in Japan. Biometals 17(5):535–538PubMed Nishijo M, Nakagawa H, Morikawa Y, Kuriwaki JI, Miura K, Kido T, Nogawa K (2004) Mortality in a cadmium polluted area in Japan. Biometals 17(5):535–538PubMed
14.
go back to reference Chen L, Wang HL, Zhu YB, Jin Z, Huang JB, Lin XF, Luo JW, Fang ZT (2020) Screening and function discussion of a hereditary renal tubular acidosis family pathogenic gene. Cell Death Dis 11(3):159PubMedPubMedCentral Chen L, Wang HL, Zhu YB, Jin Z, Huang JB, Lin XF, Luo JW, Fang ZT (2020) Screening and function discussion of a hereditary renal tubular acidosis family pathogenic gene. Cell Death Dis 11(3):159PubMedPubMedCentral
16.
go back to reference Azizi E, Eshel G, Aladjem M (1989) Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease. Eur J Pediatr 148(6):548–549PubMed Azizi E, Eshel G, Aladjem M (1989) Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease. Eur J Pediatr 148(6):548–549PubMed
17.
go back to reference Yang YS, Peng CH, Sia SK, Huang CN (2007) Acquired hypophosphatemia osteomalacia associated with Fanconi’s syndrome in Sjögren’s syndrome. Rheumatol Int 27(6):593–597PubMed Yang YS, Peng CH, Sia SK, Huang CN (2007) Acquired hypophosphatemia osteomalacia associated with Fanconi’s syndrome in Sjögren’s syndrome. Rheumatol Int 27(6):593–597PubMed
18.
go back to reference Haskelberg H, Hoy JF, Amin J, Ebeling PR, Emery S, Carr A, STEAL Study Group (2012) Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. PLoS One 7(6):e38377PubMedPubMedCentral Haskelberg H, Hoy JF, Amin J, Ebeling PR, Emery S, Carr A, STEAL Study Group (2012) Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. PLoS One 7(6):e38377PubMedPubMedCentral
19.
go back to reference Nabipour I, Sambrook PN, Blyth FM, Janu MR, Waite LM, Naganathan V, Handelsman DJ, le Couteur DG, Cumming RG, Seibel MJ (2011) Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. J Bone Miner Res 26(5):955–964PubMed Nabipour I, Sambrook PN, Blyth FM, Janu MR, Waite LM, Naganathan V, Handelsman DJ, le Couteur DG, Cumming RG, Seibel MJ (2011) Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. J Bone Miner Res 26(5):955–964PubMed
20.
go back to reference Delanaye P, Mariat C (2013) The applicability of eGFR equations to different populations. Nat Rev Nephrol 9(9):513–522PubMed Delanaye P, Mariat C (2013) The applicability of eGFR equations to different populations. Nat Rev Nephrol 9(9):513–522PubMed
21.
go back to reference (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis[J]. Am J Med 94(6):646–650 (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis[J]. Am J Med 94(6):646–650
22.
go back to reference Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393(10169):364–376PubMed Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393(10169):364–376PubMed
23.
go back to reference Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22(3):465–475PubMed Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22(3):465–475PubMed
24.
go back to reference Wang Y, Tao Y, Hyman ME, Li J, Chen Y (2009) Osteoporosis in China. Osteoporos Int 20(10):1651–1662PubMed Wang Y, Tao Y, Hyman ME, Li J, Chen Y (2009) Osteoporosis in China. Osteoporos Int 20(10):1651–1662PubMed
25.
go back to reference Hernlund E et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1–2):136PubMedPubMedCentral Hernlund E et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1–2):136PubMedPubMedCentral
26.
go back to reference van Staa TP, Dennison EM, Leufkens HGM, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29(6):517–522PubMed van Staa TP, Dennison EM, Leufkens HGM, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29(6):517–522PubMed
27.
go back to reference Grover ML, Edwards FD, Chang YHH, Cook CB, Behrens MC, Dueck AC (2014) Fracture risk perception study: patient self-perceptions of bone health often disagree with calculated fracture risk. Womens Health Issues 24(1):e69–e75PubMed Grover ML, Edwards FD, Chang YHH, Cook CB, Behrens MC, Dueck AC (2014) Fracture risk perception study: patient self-perceptions of bone health often disagree with calculated fracture risk. Womens Health Issues 24(1):e69–e75PubMed
28.
go back to reference Gregson CL et al (2014) Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int 25(1):85–95PubMed Gregson CL et al (2014) Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int 25(1):85–95PubMed
29.
go back to reference Schardijn GH, Statius VEL (1987) Beta 2-microglobulin: its significance in the evaluation of renal function. Kidney Int 32(5):635–641PubMed Schardijn GH, Statius VEL (1987) Beta 2-microglobulin: its significance in the evaluation of renal function. Kidney Int 32(5):635–641PubMed
30.
go back to reference Fu S, Guo Y, Zhang Z, Luo L, Ye P (2018) Single-marker and multi-marker approaches to appraise the relationships between biomarkers and microalbuminuria in Chinese middle-aged and elderly from communities: a cross-sectional analysis. BMC Nephrol 19(1):93PubMedPubMedCentral Fu S, Guo Y, Zhang Z, Luo L, Ye P (2018) Single-marker and multi-marker approaches to appraise the relationships between biomarkers and microalbuminuria in Chinese middle-aged and elderly from communities: a cross-sectional analysis. BMC Nephrol 19(1):93PubMedPubMedCentral
31.
go back to reference Wiebers DO, Wilson DM, McLeod RA, Goldstein NP (1979) Renal stones in Wilson’s disease. Am J Med 67(2):249–254PubMed Wiebers DO, Wilson DM, McLeod RA, Goldstein NP (1979) Renal stones in Wilson’s disease. Am J Med 67(2):249–254PubMed
32.
go back to reference Evans RD et al (2016) Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment. BMC Musculoskelet Disord 17:2PubMedPubMedCentral Evans RD et al (2016) Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment. BMC Musculoskelet Disord 17:2PubMedPubMedCentral
33.
go back to reference Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, Gattamelata A, Maset M, Modesti M, Tavoni A, de Vita S, Gerli R, Valesini G, Bombardieri S (2014) Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) 53(5):839–844 Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, Gattamelata A, Maset M, Modesti M, Tavoni A, de Vita S, Gerli R, Valesini G, Bombardieri S (2014) Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) 53(5):839–844
34.
go back to reference Lin DF, Yan SM, Zhao Y, Zhang W, Li MT, Zeng XF, Zhang FC, Dong Y (2010) Clinical and prognostic characteristics of 573 cases of primary Sjögren’s syndrome. Chin Med J 123(22):3252–3257PubMed Lin DF, Yan SM, Zhao Y, Zhang W, Li MT, Zeng XF, Zhang FC, Dong Y (2010) Clinical and prognostic characteristics of 573 cases of primary Sjögren’s syndrome. Chin Med J 123(22):3252–3257PubMed
35.
go back to reference Viganò M, Lampertico P, Mangia G, Soffredini R, Facchetti F, Invernizzi F, Colombo M (2013) 777 incidence and clinical consequences of reduced tubular phosphate re-absorption (TmPO4/GFR) in naive chronic hepatitis B patients treated with tenofovir: a two-year field study. J Hepatol 58:S316–S317 Viganò M, Lampertico P, Mangia G, Soffredini R, Facchetti F, Invernizzi F, Colombo M (2013) 777 incidence and clinical consequences of reduced tubular phosphate re-absorption (TmPO4/GFR) in naive chronic hepatitis B patients treated with tenofovir: a two-year field study. J Hepatol 58:S316–S317
36.
go back to reference Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, de Wit S, Richert L, Babiker A, Buño A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR, NEAT001/ANRS143 Study Group (2015) Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. Lancet HIV 2(11):e464–e473PubMed Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, de Wit S, Richert L, Babiker A, Buño A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR, NEAT001/ANRS143 Study Group (2015) Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. Lancet HIV 2(11):e464–e473PubMed
37.
go back to reference Gill US, Zissimopoulos A, al-Shamma S, Burke K, McPhail MJW, Barr DA, Kallis YN, Marley RTC, Kooner P, Foster GR, Kennedy PTF (2015) Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk? J Infect Dis 211(3):374–382PubMed Gill US, Zissimopoulos A, al-Shamma S, Burke K, McPhail MJW, Barr DA, Kallis YN, Marley RTC, Kooner P, Foster GR, Kennedy PTF (2015) Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk? J Infect Dis 211(3):374–382PubMed
38.
go back to reference Hall AM, Hendry BM, Nitsch D, Connolly JO (2011) Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 57(5):773–780PubMed Hall AM, Hendry BM, Nitsch D, Connolly JO (2011) Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 57(5):773–780PubMed
40.
go back to reference Kim YD, Yim DH, Eom SY, Moon SI, Park CH, Kim GB, Yu SD, Choi BS, Park JD, Kim H (2014) Differences in the susceptibility to cadmium-induced renal tubular damage and osteoporosis according to sex. Environ Toxicol Pharmacol 38(1):272–278PubMed Kim YD, Yim DH, Eom SY, Moon SI, Park CH, Kim GB, Yu SD, Choi BS, Park JD, Kim H (2014) Differences in the susceptibility to cadmium-induced renal tubular damage and osteoporosis according to sex. Environ Toxicol Pharmacol 38(1):272–278PubMed
41.
go back to reference Limpatanachote P et al (2010) Cadmium-exposed population in Mae Sot District, Tak Province: 4 bone mineral density in persons with high cadmium exposure. J Med Assoc Thail 93(12):1451–1457 Limpatanachote P et al (2010) Cadmium-exposed population in Mae Sot District, Tak Province: 4 bone mineral density in persons with high cadmium exposure. J Med Assoc Thail 93(12):1451–1457
42.
go back to reference Nakhoul N, Batuman V (2011) Role of proximal tubules in the pathogenesis of kidney disease. Contrib Nephrol 169:37–50PubMed Nakhoul N, Batuman V (2011) Role of proximal tubules in the pathogenesis of kidney disease. Contrib Nephrol 169:37–50PubMed
43.
go back to reference Blaine J, Chonchol M, Levi M (2015) Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 10(7):1257–1272PubMed Blaine J, Chonchol M, Levi M (2015) Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 10(7):1257–1272PubMed
44.
go back to reference Kuro-o M (2006) Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens 15(4):437–441PubMed Kuro-o M (2006) Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens 15(4):437–441PubMed
45.
go back to reference Miyamoto K, Ito M, Kuwahata M, Kato S, Segawa H (2005) Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial 9(4):331–335PubMed Miyamoto K, Ito M, Kuwahata M, Kato S, Segawa H (2005) Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial 9(4):331–335PubMed
46.
go back to reference Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429–435PubMed Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429–435PubMed
47.
go back to reference Murali SK, Andrukhova O, Clinkenbeard EL, White KE, Erben RG (2016) Excessive Osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice. PLoS Biol 14(4):e1002427PubMedPubMedCentral Murali SK, Andrukhova O, Clinkenbeard EL, White KE, Erben RG (2016) Excessive Osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice. PLoS Biol 14(4):e1002427PubMedPubMedCentral
48.
go back to reference Wang XQ, Zou XR, Zhang YC (2016) From “kidneys govern bones” to chronic kidney disease, diabetes mellitus, and metabolic bone disorder: a crosstalk between traditional Chinese medicine and modern science. Evid Based Complement Alternat Med 2016:4370263PubMedPubMedCentral Wang XQ, Zou XR, Zhang YC (2016) From “kidneys govern bones” to chronic kidney disease, diabetes mellitus, and metabolic bone disorder: a crosstalk between traditional Chinese medicine and modern science. Evid Based Complement Alternat Med 2016:4370263PubMedPubMedCentral
49.
go back to reference Kuro-o M (2010) Overview of the FGF23-Klotho axis. Pediatr Nephrol 25(4):583–590PubMed Kuro-o M (2010) Overview of the FGF23-Klotho axis. Pediatr Nephrol 25(4):583–590PubMed
50.
go back to reference Dunea G (1991) The Principles and Practice of Nephrology[M] Dunea G (1991) The Principles and Practice of Nephrology[M]
Metadata
Title
The urinary β2 microglobulin-creatinine ratio is inversely associated with lumbar spine bone mineral density in the elderly Chinese males
Authors
Xun Zhou
Wei Hong
Weijun Chen
Xinhui Feng
Zhenxing Zhang
Xiaoli Zhang
Chensheng Fu
Jing Xiao
Zhibin Ye
Publication date
01-12-2020
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2020
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-020-00764-x

Other articles of this Issue 1/2020

Archives of Osteoporosis 1/2020 Go to the issue